The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

Osteoporosis International

Volumn 23, Issue 8, 2012, Pages 2141-2150

  Hadji, P ^a,i   Zanchetta, J R ^b   Russo, L ^c   Recknor, C P ^d   Saag, K G ^e   McKiernan, F E ^f   Silverman, S L ^g   Alam, J ^h   Burge, R T ^h   Krege, J H ^h   Lakshmanan, M C ^h   Masica, D N ^h   Mitlak, B H ^h   Stock, J L ^h  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Instituto de Investigaciones Metabolicas   (Argentina)

^c CCBR Brazil Clinical Research Center   (Brazil)

^d United Osteoporosis Centers   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f MARSHFIELD CLINIC   (United States)

^g Cedars Sinai/UCLA and OMC Clinical Research Center   (United States)

^h ELI LILLY AND COMPANY   (United States)

ⁱ UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Back pain; Bisphosphonate; Osteoporosis; Teriparatide; Vertebral fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PARATHYROID HORMONE[1-34]; PLACEBO; RISEDRONIC ACID;

ADULT; ARTICLE; BACKACHE; BONE DENSITY; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FATALITY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HEART DISEASE; HUMAN; HYPOKALEMIA; INCIDENCE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEDIASTINUM DISEASE; MUSCLE SPASM; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATORY TRACT DISEASE; SKIN INJURY; VERTEBRA FRACTURE;

AGED; BACK PAIN; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DOUBLE-BLIND METHOD; ETIDRONIC ACID; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPOROTIC FRACTURES; PAIN MEASUREMENT; QUALITY OF LIFE; SPINAL FRACTURES; TERIPARATIDE; TREATMENT OUTCOME;

EID: 84864870959     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1856-y     Document Type: Article

References (33)

1. Nevitt MC et al (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793-800
2. Ettinger B et al (1992) Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 7:449-456
3. Silverman SL, Minshall ME, Shen W, Harper KD, Xie S (2001) The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 44:2611-2619
4. Gold DT (2001) The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am 27:255-262
5. Silverman SL, Piziak VK, Chen P, Misurski DA, Wagman RB (2005) Relationship of health related quality of life to prevalent and new or worsening back pain in postmenopausal women with osteoporosis. J Rheumatol 32:2405-2409
6. Langdahl BL et al (2009) Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int 85:484-493
7. Neer RM et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
8. Lyritis G et al (2010) Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Curr Med Res Opin 26:1799-1807
9. Fahrleitner-Pammer A et al (2010) Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporos Int 22(10):2709-2719
10. Farrar JT, Young JP Jr., LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149-158
11. Dworkin RH et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9:105-121
12. Ostelo RW et al (2008) Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976) 33:90-94
13. Fechtenbaum J et al (2005) The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women. Osteoporos Int 16:2175-2179
14. Lips P et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int 10:150-160
15. Genant HK, Wu CY, Van KC, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148
16. Looker AC et al (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761-1768
17. Shipp KM et al (2000) Timed loaded standing: a measure of combined trunk and arm endurance suitable for people with vertebral osteoporosis. Osteoporos Int 11:914-922
18. Harden RN et al (2005) Medication Quantification Scale Version III: update in medication classes and revised detriment weights by survey of American Pain Society Physicians. J Pain 6:364-371
19. Minne H et al (2008) Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study. Curr Med Res Opin 24:3117-3128
20. Kallmes DF et al (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361:569-579
21. McClung MR et al (2005) Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165:1762-1768
22. Saag KG et al (2007) Teriparatide or alendronate in glucocorticoidinduced osteoporosis. N Engl J Med 357:2028-2039
23. Saag KG et al (2009) Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum 60:3346-3355
24. Lindsay R et al (2009) Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis. Osteoporos Int 20:943-948
25. Genant HK, Siris E, Crans GG, Desaiah D, Krege JH (2005) Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index. Bone 37:170-174
26. Prevrhal S, Krege JH, Chen P, Genant H, Black DM (2009) Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment. Curr Med Res Opin 25:921-928
27. Black DM et al (1999) Defining incident vertebral deformity: a prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:90-101
28. Pluijm SM, Tromp AM, Smit JH, Deeg DJ, Lips P (2000) Consequences of vertebral deformities in older men and women. J Bone Miner Res 15:1564-1572
29. Genant HK et al (2005) The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis. Curr Med Res Opin 21:1027-1034
30. Miller PD et al (2005) Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. J Rheumatol 32:1556-1562
31. Nevitt MC et al (2006) Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis. Osteoporos Int 17:1630-1637
32. Nevitt MC et al (2006) Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 17:273-280
33. Bashutski JD et al (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363:2396-2405